RAD18 and cancer: Accumulating evidence indicates that the expression level of RAD18 contributes to mutagenesis and DNA damage-based cancer therapy resistance [10–19], hinting the necessity and significance of understanding the regulatory mechanism governing RAD18 function in maintaining genome stability and tumorigenesis.